|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 9/2077 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61K 47/36 | (2013.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 31/53 | (2013.01) |
| (11) | Number of the document | 4058028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20820686.2 |
| Date of filing the European patent application | 2020-11-13 | |
| (97) | Date of publication of the European application | 2022-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/060340 |
| Date | 2020-11-13 |
| (87) | Number | WO 2021/097160 |
| Date | 2021-05-20 |
| (30) | Number | Date | Country code |
| 201962935581 P | 2019-11-14 | US |
| (72) |
MITRA, Biplob K. , US
AYCINENA, J. Alex , US
RUMONDOR, Alfred C.F. , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (54) | PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER |
| PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER |